A Retrospective Claims Study Evaluating Mortality in Patients With Lennox-Gastaut or Dravet Syndromes in the United States (P8-11.004)

dc.contributor.authorRejena Ameen
dc.contributor.authorElaine Wirrell
dc.contributor.authorJoseph Sullivan
dc.contributor.authorTravis Zuroske
dc.contributor.authorD Grochowski
dc.contributor.authorShalini Gupta
dc.contributor.authorRebecca Zhang-Roper
dc.contributor.authorAmélie Lothe
dc.contributor.authorWesley T. Kerr
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T19:35:18Z
dc.date.available2026-03-22T19:35:18Z
dc.date.issued2025
dc.description.abstractTo analyze real-world mortality rates in patients with Lennox-Gastaut (LGS) or Dravet syndromes (DS) in the US.
dc.identifier.doi10.1212/wnl.0000000000210586
dc.identifier.urihttps://doi.org/10.1212/wnl.0000000000210586
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/76931
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofNeurology
dc.sourceMayo Clinic in Arizona
dc.subjectDravet syndrome
dc.subjectPediatrics
dc.subjectLennox–Gastaut syndrome
dc.subjectMedicine
dc.subjectRetrospective cohort study
dc.subjectEpilepsy
dc.titleA Retrospective Claims Study Evaluating Mortality in Patients With Lennox-Gastaut or Dravet Syndromes in the United States (P8-11.004)
dc.typearticle

Files